Filing Flows › Comparisons › NVCR vs UFPT
NovoCure vs UFP Technologies: NVCR and UFPT compared
NovoCure is the larger company: $193M of revenue in its latest quarter (Q3 2026) against $172M for UFP Technologies (Q3 2026). NovoCure is growing faster (+16% against +12% a year earlier). UFP Technologies is more profitable, with an operating margin of 16.0% against -3.2%.
Where the money goes: NVCR and UFPT
NovoCure (NVCR) · Q3 2026
NovoCure, Q3 2026: revenue $193M (+16% year over year), operating margin -3.2%, net loss $10.4M, operating cash flow $22.7M. The chart follows the revenue to costs, profit and cash.
UFP Technologies (UFPT) · Q3 2026
UFP Technologies, Q3 2026: revenue $172M (+12% year over year), operating margin 16.0%, net earnings $20.6M, operating cash flow $38.5M. The chart follows the revenue to costs, profit and cash.
| NovoCure (NVCR) | UFP Technologies (UFPT) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 2026 |
| Revenue | $193M | $172M |
| Revenue growth, Y/Y | +16% | +12% |
| Gross margin | — | 29.4% |
| Operating margin | -3.2% | 16.0% |
| Net earnings | −$10.4M | $20.6M |
| Net margin | -5.4% | 12.0% |
| Operating cash flow | $22.7M | $38.5M |
| Free cash flow | $15.7M | $34.6M |
| Market value | — | $2.3B |
| P/E | — | 31.4× |
| Analysts’ mean target | — | $355.00 |
Where the revenue comes from
UFP Technologies
- Products: $169M (98%)
- Engineering services: $2.0M (1%)
- Tooling and machinery: $1.5M (1%)
Questions
Which is bigger, NovoCure or UFP Technologies?
NovoCure is the larger company: $193M of revenue in its latest quarter (Q3 2026) against $172M for UFP Technologies (Q3 2026).
Is NovoCure or UFP Technologies growing faster?
NovoCure is growing faster (+16% against +12% a year earlier).
Which is more profitable, NovoCure or UFP Technologies?
UFP Technologies is more profitable, with an operating margin of 16.0% against -3.2%.
More: NovoCure earnings · how NovoCure makes money · UFP Technologies earnings · how UFP Technologies makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Oct 29, 2026; 10-Q filed Nov 6, 2026). Fiscal quarters can end on different dates. Not investment advice.